ALLENA PHARMACEUTICALS INC's ticker is ALNA and the CUSIP is 018119107. A total of 50 filers reported holding ALLENA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 1.4%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer VII & Co. Ltd. | 2,263,365 | $22,448,000 | 83.81% |
| Pharmstandard International S.A. | 1,037,267 | $11,431,000 | 28.71% |
| Partner Investment Management, L.P. | 575,407 | $5,697,000 | 6.16% |
| FRAZIER MANAGEMENT LLC | 3,330,373 | $36,701,000 | 6.09% |
| TRV GP II, LLC | 2,790,964 | $30,756,000 | 5.76% |
| SPHERA FUNDS MANAGEMENT LTD. | 410,199 | $4,520,000 | 0.69% |
| PFM Health Sciences, LP | 1,463,894 | $15,241,000 | 0.31% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 18,288 | $310,000 | 0.09% |
| Perceptive Advisors | 250,000 | $2,755,000 | 0.08% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 61,000 | $672,000 | 0.01% |